Featured Article

Is Agentic AI The ‘Next Leap Forward’ for Clinical Trial Data Management?

In clinical trials, every second counts, both for patient outcomes and sponsor ROI. As data volumes grow and oversight expectations tighten under frameworks like ICH E6(R3), teams are being asked to do more, faster and with greater precision. It is no surprise then that agentic AI, which promises to deliver efficiencies far beyond previous models, is the current hot topic across the industry. Analysis suggests agentic AI could transform eight out of 10 workflows and up to 95% of life science roles may have agentic teammates in the future.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Blog
ICH E6(R3), Demystified Part 4: Informed Consent
Blog
RBQM for the Mid-Market Explained
Blog
5 Myths Mid-Market Teams Believe About RBQM and What ICH E6(R3) Actually Requires